ApiJect Systems Corp., a public-benefit medical technology company, has recently secured an initial grant of $425,000 from the Bill & Melinda Gates Foundation. This significant funding aims to support the design and development of low-cost Prefilled ApiJect Injectors to make single-use
Recent developments in the pharmaceutical industry underscore the volatile nature of advancements and market dynamics affecting prominent companies. The latest updates reveal a mix of struggles and achievements that highlight how pharmaceutical giants are navigating the complexities of drug
Sterling Pharma Solutions is significantly expanding its GMP antibody-drug conjugate (ADC) manufacturing capacity with a £10 million investment aimed at doubling the current capacity at its Deeside, UK site. This expansion involves commissioning a new 2,300-square-foot suite, which includes a
Global biopharma giant GSK (GlaxoSmithKline) has made a monumental decision to significantly expand its facility in Marietta, Lancaster County, Pennsylvania. The pharmaceutical company is committing up to $800 million to enhance its research, development, and manufacturing capabilities. This
PureTech Health, a Boston-based biotechnology firm, employs an innovative "hub-and-spoke" model, centralizing resources and expertise to support various offshoot companies focused on specific therapeutic areas or drug-making technologies. This approach aims to merge the strengths of a
Sutro Biopharma, Inc. (NASDAQ:STRO) has experienced a dramatic drop in its stock value over the last three years, significantly impacting its shareholders who have seen their investments diminish by 80%. Despite the company's impressive annual revenue growth of 38%, this financial success
